Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is May 23, 2024.
All times in Eastern Daylight Time.
-
Dentalcorp Announces Annual General Meeting Voting ResultsTORONTO--(BUSINESS WIRE)--Dentalcorp Holdings Ltd. ("Dentalcorp" or the "Company"), (TSX: DNTL) Canada’s largest and one of North America's fastest growing networks of dental practices, announced t... more »
-
AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid CancerNATICK, Mass.--(BUSINESS WIRE)--AffyImmune Announces Confirmed Complete Response in Patient with Anaplastic Thyroid Cancer more »
-
Incendia Therapeutics Announces Upcoming Presentation with PathAI at the 2024 American Society of Clinical Oncology Annual MeetingCAMBRIDGE, Mass.--(BUSINESS WIRE)--Incendia Therapeutics, a precision oncology company discovering and developing a novel class of therapies that reprogram the tumor microenvironment (TME), today a... more »
-
Comvest Partners Announces $70 Million Senior Credit Facility For Nationwide Energy Partners to Support Growth StrategyWEST PALM BEACH, Fla.--(BUSINESS WIRE)--Comvest Partners, a leading middle-market private equity and credit investment firm, is pleased to announce that its direct lending platform, Comvest Credit ... more »
-
SOTIO Presents Overview of DUET-01 Phase 1/2 Study at ASCO Annual MeetingPRAGUE & BASEL, Switzerland & BOSTON--(BUSINESS WIRE)--SOTIO to present Trial-in-Progress poster on the first-in-human DUET-01 Phase 1/2 study at 2024 ASCO Annual Meeting. more »
-
NeraCare Announces Publication of Abstract on Clinical Validation of a Prognostic 7-Biomarker Assay for Prediction of Relapse in Patients with Early-Stage Cutaneous Melanoma at the 2024 American Society of Clinical Oncology (ASCO) Annual MeetingFRANKFURT, Germany--(BUSINESS WIRE)--NeraCare, a leading developer of laboratory tests for personalized survival prediction of melanoma patients, today announced publication of an abstract describi... more »
-
Orca Bio to Present Positive Clinical Outcomes with Orca-T in Patients with AML at 2024 ASCO Annual MeetingMENLO PARK, Calif.--(BUSINESS WIRE)--Orca Bio, a biotechnology company committed to transforming the lives of patients through high-precision cell therapy, today announced it will present new data ... more »
-
Merck to Showcase Advances in the Science of Cancer With New Data Presented at ASCO 2024DARMSTADT, Germany--(BUSINESS WIRE)--Merck, a leading science and technology company, today announced new research from the company’s diverse oncology portfolio will be presented at the 2024 Americ... more »
-
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Obsidian Therapeutics, Inc., a clinical-stage biotechnology company pioneering engineered cell and gene therapies, today announced positive updated safety and eff... more »
-
Klaviyo to Present at the William Blair Growth Stock ConferenceBOSTON--(BUSINESS WIRE)--Klaviyo (NYSE: KVYO), the company that powers smarter digital relationships, today announced that Amanda Whalen, Chief Financial Officer, will participate in a fireside cha... more »
-
Genmab to Showcase Data in Various Patient Populations to be Presented at the American Society of Clinical Oncology (ASCO) Annual MeetingCOPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today that multiple abstracts evaluating epcoritamab, a T-cell engaging bispecific antibody administered subcutaneously, ti... more »
-
Legend Biotech to Highlight Leadership in CAR-T Cell Therapy for Patients with Multiple Myeloma at ASCO and EHASOMERSET, N.J.--(BUSINESS WIRE)--Legend Biotech Corporation (NASDAQ: LEGN) (Legend Biotech), a global leader in cell therapy, announced today that new and updated data from the CARTITUDE clinical d... more »
-
Xspray to present data at ASCO highlighting frequent comedication of PPIs with TKIs in CML-patients and greater than expected negative effects on the bioavailability of crystalline dasatinibSTOCKHOLM--(BUSINESS WIRE)--Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY), a Swedish pharmaceutical company which uses its innovative Hynap technology to develop 505(b)(2) improved versions of... more »
-
Iambic Therapeutics Announces Poster Presentation for IAM1363, a Clinical Stage Type II HER2 Inhibitor, at the 2024 ASCO Annual MeetingSAN DIEGO--(BUSINESS WIRE)--Iambic Therapeutics, a clinical-stage biotechnology company developing novel therapeutics using its unique AI-driven discovery platform, today announced a poster present... more »
-
City of Hope Researchers to Present Investigational Treatments for Colorectal, Kidney and Blood Cancers at 2024 American Society of Clinical Oncology (ASCO) Annual MeetingLOS ANGELES--(BUSINESS WIRE)--World-renowned physicians and researchers from City of Hope®, one of the largest cancer research and treatment organizations in the United States, will present new dat... more »